The interleukin (IL-1) receptor is a critical component in mediating the highly inflammatory responses of IL-1, which affects nearly every cell type. We have recently demonstrated that the activation of the transcription factor NF-kappaB depends not only upon the previously characterized IRAK pathway, but also a novel independent pathway involving IL-1 receptor tyrosine phosphorylation and recruitment and catalytic activation of phosphatidylinositol 3-kinase (PI3K). We propose to further study the involvement of this pathway in NF-kappaB activation and the activation of other transcription factors induced by IL-1. Additionally, we propose to investigate whether various signaling pathways mediated by the IL-1 receptor system converge with one or the other of the two distinct pathways.
Five specific aims are proposed: The first is designed to understand the detailed mechanism of NF-kappaB activation by PI3K focusing on the identification of the essential regions of the receptor cytoplasmic domain, the identity of the required critical tyrosine kinase, and the target sites on NF-kappaB and/or IkappaB required for activation.
The second aim will explore the relationship between PI3K and other IL-1 induced signals such as MAPK and the direct target of PI3K.
The third aim will investigate the molecular requirements for interactions among IL-1 receptor components including receptor heteromers, P13K, and IRAK. The fourth specific aim will identify regions of the receptor cytoplasmic domain and associated molecules involved in the activation of other IL-1-inducible transcription factors such as C/EBPbeta, Stat3, and the novel LPS/IL-1/IL-6 responsive LIL-Stat factor that we recently described. The identification of the recruitment sites for STAT factor activation and the target phosphorylation site on C/EBPbeta will be determined. The fifth aim will investigate the interplay between signal transduction pathways and the association of the IL-1 ligand with the receptor ectodomains as defined by IL-1 ligand mutations which we previously described as being capable of eliciting distinct signaling events. A new IL-1 mutation extends the earlier data arguing for an interplay between signal transduction pathways and the association of the IL-1 ligand with the receptor.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Research Project (R01)
Project #
Application #
Study Section
Allergy and Immunology Study Section (ALY)
Program Officer
Hackett, Charles J
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Beth Israel Deaconess Medical Center
United States
Zip Code
Listman, James A; Race, JoAnne E; Walker-Kopp, Nancy et al. (2008) Inhibition of IL-1beta transcription by peptides derived from the hCMV IE2 transactivator. Mol Immunol 45:2667-77
Unlu, Sebnem; Kumar, Arvind; Waterman, Wayne R et al. (2007) Phosphorylation of IRF8 in a pre-associated complex with Spi-1/PU.1 and non-phosphorylated Stat1 is critical for LPS induction of the IL1B gene. Mol Immunol 44:3364-79
Wang, Kent Z Q; Wara-Aswapati, Nawarat; Boch, Jason A et al. (2006) TRAF6 activation of PI 3-kinase-dependent cytoskeletal changes is cooperative with Ras and is mediated by an interaction with cytoplasmic Src. J Cell Sci 119:1579-91
Yoshida, Yasuhiro; Kumar, Arvind; Koyama, Yoshinobu et al. (2004) Interleukin 1 activates STAT3/nuclear factor-kappaB cross-talk via a unique TRAF6- and p65-dependent mechanism. J Biol Chem 279:1768-76
Boch, Jason A; Yoshida, Yasuhiro; Koyama, Yoshinobu et al. (2003) Characterization of a cascade of protein interactions initiated at the IL-1 receptor. Biochem Biophys Res Commun 303:525-31
Asea, Alexzander; Rehli, Michael; Kabingu, Edith et al. (2002) Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4. J Biol Chem 277:15028-34